Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. | Zendy

Fabio Lattanzi | Zendy; Eugenio Picaño | Zendy; Leonardo Bolognese | Zendy; Cristina Piccinino | Zendy; G Sarasso | Zendy; Andrés Orlandini | Zendy; Antonio LʼAbbate | Zendy

Open Access

Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography.

Author(s) -

Fabio Lattanzi,

Eugenio Picaño,

Leonardo Bolognese,

Cristina Piccinino,

G Sarasso,

Andrés Orlandini,

Antonio LʼAbbate

Publication year - 1991

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.83.4.1256

Subject(s) - dipyridamole , medicine , coronary artery disease , cardiology , ischemia , anesthesia , electrocardiography , st segment , myocardial infarction

Dipyridamole echocardiography test (DET: two-dimensional echocardiographic monitoring with dipyridamole infusion up to 0.84 mg/kg in 10 minutes) is a useful tool for the noninvasive diagnosis of coronary artery disease. Aims of the present study were to assess the effects of antianginal drugs on dipyridamole-induced ischemia and to evaluate whether drug-induced changes in DET response may predict variations in exercise tolerance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research